Development and internal validation of a risk prediction model for ipsilateral upper-limb lymphedema following breast cancer surgery - Top-Institutions - MDSpire

Development and internal validation of a risk prediction model for ipsilateral upper-limb lymphedema following breast cancer surgery

  • By

  • Yufei Fan

  • Gaofeng Yang

  • Yumeng Zeng

  • Yanfei Lu

  • Fan Feng

  • Xiudi Wang

  • June 3, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Hangzhou Women’s Hospital
    Hangzhou Women’s Hospital

    Hangzhou, Zhejiang

    Key Differentiators

    • Oncology
    • Breast Surgery

  • #2

    Beijing Shijitan Hospital
    Beijing Shijitan Hospital

    Beijing, Beijing

    Key Differentiators

    • Oncology

  • #3

    The Ohio State University Comprehensive Cancer Center
    The Ohio State University Comprehensive Cancer Center

    Columbus, Ohio

    Key Differentiators

    • Oncology

  • #4

    Zhejiang Cancer Hospital
    Zhejiang Cancer Hospital

    Hangzhou, Zhejiang

    Key Differentiators

    • Oncology

Original Source(s)

Development and internal validation of a risk prediction model for ipsilateral upper-limb lymphedema following breast cancer surgery

  • by Yufei Fan, Gaofeng Yang, Yumeng Zeng, Yanfei Lu, Fan Feng, Xiudi Wang

  • June 3, 2026

Related Content

MIT president: Why so many optimistic scientists are losing heart

Recent advances in dissolving microneedles for breast cancer immunotherapy: local delivery and tumor microenvironment remodeling

Artificial intelligence improves risk stratification for breast cancer recurrence and mortality in women exposed to pesticides: a call for reassessment of stratification criteria